Insulet Corporation (PODD) Stock

Healthcare · Medical Devices · Member of S&P 500

Insulet Corporation (PODD) closed at USD 133.93 on 2026-10-14, a change of -58.7 % over the past year, with a market capitalization of USD 9.62B.

Insulet Corporation recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Insulet Corporation key figures

Previous close

USD 133.93 (2026-10-14)

1-year change

-58.7 %

Market cap

USD 9.62B

Enterprise value

USD 10.04B

P/E ratio (trailing)

25.84

P/E ratio (forward)

17.97

EPS (trailing)

5.37

EPS (forward)

7.72

PEG ratio

1.05

Price to book

6.77

Revenue growth

23.5 %

Earnings growth

328.6 %

Dividend per share (trailing)

0.00

Short ratio

3.08

Employees

5,400

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Insulet Corporation and compare it with other stocks.